PATENT CLAIM ANALYSIS

Application Number: 15743601
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "157000"]

Abstract:
Disclosed herein are compounds having the following structure useful as inhibitors of carbonic anhydrase IX (CAIX) and XII, and particularly useful for reducing or eliminating metastases see Formula (I).

Claim (Index 13):
A method for treating a mammal having cancer comprising administering to said mammal a therapeutically effective amount of the compound according to  claim 1 , wherein the cancer is astrocytoma/glioblastoma, bladder cancer, breast cancer, colorectal carcinoma, esophageal adenocarcinoma, gastrointestinal stromal tumors, gastric cancer, head and neck cancer, hepatocellular carcinoma, lung cancer, melanoma, ovarian cancer, pancreatic ductal adenocarcinoma, renal cell carcinoma, thyroid cancer, or uterine endometrial cancer.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.12903
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14795837', '14355552', '13737704', '15631417', '12695636']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7668371534691307
- 35 USC 102 Novelty (BERT): 0.5073552018718622
- Combined Prediction Score: 0.7408889583094038
- Mean Citation Score: 267.4747
- Max Citation Score: 280.91833
- Similarity Product: 205.02911220622

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test